Bengaluru: With more than 130 crore as its population, India is all set to inoculate its people. in the first phase, at least 30 crore people, by the end of July, will get the vaccine. 

The vaccine administered will be Covishield, manufactured by Ox ford University and AstraZeneca. 


As per reports, two full doses of the vaccine must be administered to an individual in a gap of 4-6 weeks. Reports also add that the one being administered will be given a factsheet. 

The Subject Expert Committee of the drug regulator will submit the findings of adverse events once every fortnight. 
Reports also add that a dry run has been scheduled today (January 2) in at least three ‘session sites’ in every state capital and districts with poor logistical support.

The objective of the government, as reports add, behind this exercise, is to assess the on-field situation of the vaccination process. At the same time, a total of 96000 vaccinators have been trained to execute the inoculation programme. The government has directed all states to be ready with the list of health workers, who would be vaccinated first.      



Drugs Controller General of India will be giving its nod for the vaccine in a day or two, reports further add. 

OpIndia quoted an official as saying: “Preparations are in full swing. As soon as DCGI approves the EVA, the government will place a formal contract or supply order with the manufacturer along with details of supply schedule and locations”.

Prioritising the population for vaccination: 

The central government is planning to administer it to 30 crore people by July. First in line with be heathcare workers like doctors, nurses, paramedics and hospital staff. 


After this, people who are aged 50 and more and those with comorbidities will get it. 

It is only then that the rest of the population will receive the vaccine.